News NextCell Pharma AB

Equities

NXTCL

SE0009723125

Market Closed - Nasdaq Stockholm Other stock markets 09:38:50 2024-05-17 am EDT			5-day change	1st Jan Change
1.28 ^SEK	-0.78%		+1.99%	-51.33%

Apr. 25	NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI
Apr. 22	NextCell Pharma AB Announces Swedish Health and Social Care Inspectorate Grants Their Cellaviva Tissue Establishment Permission to Handle Amniotic Tissue	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NextCell publishes its Interim Report 2 2023/2024	Apr. 25	AQ
NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	Apr. 25	CI
Notice of Extraordinary General Meeting in NextCell Pharma AB (publ)	Apr. 24	AQ
The Board of Directors of NextCell resolves on a rights issue of units of approximately SEK 40.1 million, subject to approval by an Extraordinary General Meeting	Apr. 24	AQ
NextCell's daughter company Cellaviva granted permission to handle amniotic tissue	Apr. 22	AQ
NextCell Pharma AB Announces Swedish Health and Social Care Inspectorate Grants Their Cellaviva Tissue Establishment Permission to Handle Amniotic Tissue	Apr. 22	CI
NextCell Pharma Chairman to Step Down in May	Apr. 19	MT
Anders Essen-Möller resigns as Chairman of the Board of Directors due to health reasons	Apr. 19	AQ
Anders Essen-Möller Resigns as Chairman of NextCell Pharma AB	Apr. 19	CI
The Swedish Medical Products Agency approves subgroup analysis in NextCell's ProTrans-Young study	Mar. 27	AQ
The Swedish Medical Products Agency Approves Subgroup Analysis in NextCell Pharma AB's ProTrans-Young study	Mar. 27	CI
NextCell establishes QVance to meet the Nordic's need for quality analytics	Mar. 14	AQ
NextCell Pharma AB Establishes QVance to Meet the Nordic's Need for Quality Analytics	Mar. 14	CI
NextCell Pharma's updated growth strategy	Feb. 27	AQ
NextCell Pharma presents at Redeye Theme: Regenerative Medicine/Cell Therapy	Feb. 14	AQ
NextCell Pharma AB Reports Earnings Results for the First Quarter Ended November 30, 2023	Jan. 25	CI
NextCell publishes its Interim Report 1 2023/2024	Jan. 25	AQ
Updates regarding NextCell's Clinical Trials with ProTrans	Jan. 24	AQ
Nextcell Pharma Announces Updates Regarding Nextcell's Clinical Trials with Protrans	Jan. 24	CI
NextCell Pharma has compiled a Q&A section	Dec. 13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NextCell Pharma AB

Equities

NXTCL

SE0009723125

Summary

Filters